◆英語タイトル：OSE Immunotherapeutics (OSE) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
OSE Immunotherapeutics (OSE), formerly OSE Pharma SA, is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and breast cancer. It provides products such as tedopi and effi-7. OSE’s Effi-7 is in preclinical development and targets autoimmune diseases and transplantation. OSE’s tedopi stimulates cytotoxic killer T cells and relearns them to detect cancer cells to eliminate them. The company offers pipeline products such as OSE-172, OSE-703, FR104, 0SE-127. It markets its products through its distribution network. OSE is headquartered in Nantes, Pays-de-la-Loire, France.
OSE Immunotherapeutics Key Recent Developments
Mar 26,2021: OSE Immunotherapeutics Reports 2020 Financial Results and Provides Business Update
Jan 28,2021: OSE Immunotherapeutics expands its collaboration with MAbSilico to use artificial intelligence to accelerate drug development of novel antibody therapeutics
Nov 09,2020: OSE Immunotherapeutics to present at SITC annual meeting and at additional international immuno-oncology summits
Sep 17,2020: OSE Immunotherapeutics reports first half 2020 results and corporate update
Jun 16,2020: OSE Immunotherapeutics announces results of 2020 virtual combined general meeting
This comprehensive SWOT profile of OSE Immunotherapeutics provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OSE Immunotherapeutics including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
OSE Immunotherapeutics – Key Information
OSE Immunotherapeutics – Overview
OSE Immunotherapeutics – Key Employees
OSE Immunotherapeutics – Key Employee Biographies
OSE Immunotherapeutics – Key Operational Heads
OSE Immunotherapeutics – Major Products and Services
OSE Immunotherapeutics – History
OSE Immunotherapeutics – Company Statement
OSE Immunotherapeutics – Locations And Subsidiaries
Other Locations & Subsidiaries
Section 2 – Company Analysis
OSE Immunotherapeutics – Business Description
OSE Immunotherapeutics – Corporate Strategy
OSE Immunotherapeutics – SWOT Analysis
SWOT Analysis – Overview
OSE Immunotherapeutics – Strengths
OSE Immunotherapeutics – Weaknesses
OSE Immunotherapeutics – Opportunities
OSE Immunotherapeutics – Threats
OSE Immunotherapeutics – Key Competitors
Section 3 – Company Financial Performance Charts
OSE Immunotherapeutics – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
OSE Immunotherapeutics, Key Information
OSE Immunotherapeutics, Key Ratios
OSE Immunotherapeutics, Share Data
OSE Immunotherapeutics, Major Products and Services
OSE Immunotherapeutics, History
OSE Immunotherapeutics, Key Employees
OSE Immunotherapeutics, Key Employee Biographies
OSE Immunotherapeutics, Key Operational Heads
OSE Immunotherapeutics, Other Locations
OSE Immunotherapeutics, Subsidiaries
OSE Immunotherapeutics, Key Competitors
OSE Immunotherapeutics, SWOT Analysis
OSE Immunotherapeutics, Ratios based on current share price
OSE Immunotherapeutics, Annual Ratios
OSE Immunotherapeutics, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[OSE Immunotherapeutics (OSE)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら